Gitlab Inc
For the period ended Apr 30, 2024. Filed Jun 4, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Apr 30, 2024 · Filed Jun 4, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Condensed Consolidated Financial Statements
- Organization and Description of Business
GitLab Inc. (the “Company”) began as an open source project in 2011 and was incorporated in Delaware on September 12, 2014. The Company operates on an all-remote model. The Company is a technology company and its primary offering is “GitLab”, a complete DevSecOps platform delivered as a single application. GitLab is used by a wide range of organizations. The Company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service ("SaaS") models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The Company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world to help them become better software-led businesses.
- Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP.
Fiscal Year
The Company's fiscal year ends on January 31. For example, references to fiscal year 2025 and 2024 refer to the fiscal year ending January 31, 2025 and the fiscal year ended January 31, 2024, respectively.
Use of Estimates
The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates include, but are not limited to, allocation of revenue to the license element in the Company's self-managed subscriptions, estimating the amortization period for capitalized costs to obtain a contract, allowance for doubtful accounts, stock-based compensa tion expense, fair value of contingent consideration, fair valuation of retained interest in an investee on loss of control, valuation allowance for deferred income taxes, reserves for unrecognized income tax benefits, valuation of acquired intangibles assets and impairment of goodwill and equity method investments. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.
Principles of Consolidation
The condensed consolidated financial statements include 100% of the accounts of wholly owned and majority owned subsidiaries as well as a variable interest entity for which the Company is the primary beneficiary. The ownership interest of other investors is recorded as noncontrolling interest. All intercompany accounts and transactions have been eliminated in consolidation.
Summary of Significant Accounting Policies
There were no significant changes to the Company’s significant accounting policies disclosed in “Note 2” of the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2024.
- Revenues
Disaggregation of Revenue
The following table shows the components of revenues and their respective percentages of total revenue for the periods indicated (in thousands, except percentages):
| Three Months Ended April 30, | ||||
|---|---|---|---|---|
| 2024 · 2023 | ||||
| Subscription—self-managed and SaaS | $151,179 | 89% | $111,191 | 88% |
| Subscription—self-managed | 103,673 | 61 | 79,587 | 63 |
| SaaS | 47,506 | 28 | 31,604 | 25 |
| License—self-managed and other | $18,008 | 11% | $15,687 | 12% |
| License—self-managed | 14,837 | 9 | 13,355 | 10 |
| Professional services and other | 3,171 | 2 | 2,332 | 2 |
| Total revenue | $169,187 | 100% | $126,878 | 100% |
Total Revenue by Geographic Location
The following table summarizes the Company’s total revenue by geographic location based on the region of the Company’s contracting entity, which may be different than the region of the customer (in thousands):
| Three Months Ended April 30, | ||
|---|---|---|
| 2024 | 2023 | |
| United States | $137,526 | $102,962 |
| Europe | 27,652 | 20,957 |
| Asia Pacific | 4,009 | 2,959 |
| Total revenue | $169,187 | $126,878 |
During thethree months ended April 30, 2024 and 2023, the United States accountedfor 81% of total revenue. No other individual country exceeded 10% of total revenue for any of the periods presented.
The Company operates its business as a single operating segment.
Deferred Revenue
During thethree months ended April 30, 2024 and 2023, $125.3 million and $90.6 million, respectively, of revenue was recognized, which was included in the corresponding deferred revenue balance at the beginning of the periods presented.
Remaining Performance Obligations
As of April 30, 2024 and January 31, 2024, the aggregate amount of the transaction price allocated to billed and unbilled remaining performance obligations for which revenue has not yet been recognized was approximately $681.2 million and $673.8 million, respectively. As of April 30, 2024, the Company expects to recognize approximately 64% of the transaction price as product or services revenue over the next 12 months and 87% over the next 24 months.
Concentration of Credit Risk and Significant Customers
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, short-term investments, and accounts receivable. At times, cash deposits may be in excess of insured limits. The Company believes that the financial institutions or corporations that hold its cash, cash equivalents, restricted cash, and short-term investments are financially sound and, accordingly, minimal credit risk exists with respect to these balances. The Company maintains allowances for potential credit losses on accounts receivable when deemed necessary.
The Company uses various distribution channels. As of April 30, 2024, two of these channel partners represented 10% and 14% of the accounts receivable balance, respectively, while as of January 31, 2024, two of these channel partners represented 12% and 13% of the accounts receivable balance, respectively. There were no individual customers whose balance represented more than 10% of accounts receivable as of April 30, 2024 and January 31, 2024.
There were no individual customers whose revenue represented more than 10% of total revenue duringthe three months ended April 30, 2024 and 2023.
- Cash, Cash Equivalents and Short-Term Investments
The following table summarizes the Company’s cash equivalents and short-term investments by category (in thousands):
| As of April 30, 2024 | ||||
|---|---|---|---|---|
| Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |
| Level 1: | ||||
| Cash equivalents (1) | ||||
| Money market funds | $259,744 | $— | $— | $259,744 |
| Level 2: | ||||
| Cash equivalents (1) | ||||
| U.S. Treasury securities | 57,887 | — | (3) | 57,884 |
| Commercial paper | 12,916 | — | (3) | 12,913 |
| Total cash equivalents | 330,547 | — | (6) | 330,541 |
| Short-term investments | ||||
| Commercial paper | 27,592 | 2 | (17) | 27,577 |
| Corporate debt securities | 212,399 | 30 | (692) | 211,737 |
| U.S. Agency securities | 48,848 | — | (153) | 48,695 |
| U.S. Treasury securities | 353,904 | — | (740) | 353,164 |
| Total short-term investments | 642,743 | 32 | (1,602) | 641,173 |
| Level 2 total | 713,546 | 32 | (1,608) | 711,970 |
| Total cash equivalents and short-term investments | $973,290 | $32 | $(1,608) | $971,714 |
(1) Included in “cash and cash equivalents” in our condensed consolidated balance sheet as of April 30, 2024, in addition to cash of $89.8 million.
| As of January 31, 2024 | ||||
|---|---|---|---|---|
| Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |
| Level 1: | ||||
| Cash equivalents (1) | ||||
| Money market funds | $187,175 | $— | $— | $187,175 |
| Level 2: | ||||
| Cash equivalents (1) | ||||
| U.S. Treasury securities | 15,909 | — | (2) | 15,907 |
| Commercial paper | 3,962 | — | (1) | 3,961 |
| Total cash equivalents | 207,046 | — | (3) | 207,043 |
| Short-term investments | ||||
| Commercial paper | 23,229 | 14 | (1) | 23,242 |
| Corporate debt securities | 231,219 | 740 | (250) | 231,709 |
| U.S. Agency securities | 56,324 | 29 | (136) | 56,217 |
| U.S. Treasury securities | 437,369 | 141 | (389) | 437,121 |
| Total short-term investments | 748,141 | 924 | (776) | 748,289 |
| Level 2 total | 768,012 | 924 | (779) | 768,157 |
| Total cash equivalents and short-term investments | $955,187 | $924 | $(779) | $955,332 |
(1) Included in “cash and cash equivalents” in our condensed consolidated balance sheet as of January 31, 2024, in addition to cash of$81.0 million.
The fair value of the Company’s Level 1 financial instruments, such as money market funds which are traded in active markets, is based on quoted market prices for identical instruments. The fair value of the Company’s Level 2 financial instruments such as commercial paper, corporate debt and U.S. government securities are obtained from an independent pricing service, which may use inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security that may not be actively traded. The Company’s marketable securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models.
The Company uses the specific-identification method to determine any realized gains or losses from the sale of the Company’s short-term investments classified as available-for-sale. For the three months ended April 30, 2024 and 2023, the Company did not have any material realized gains or losses as a result of maturities or sales of short-term investments.
During thethree months ended April 30, 2024 and 2023, the Company recorded $12.0 million and $7.3 million of interest income on cash and cash equivalents and short-term investments, respectively, which includes $4.9 million and $3.6 million of net amortization of premiums or discounts on short-term investments during the three months ended April 30, 2024 and 2023, respectively.
The following table summarizes unrealized losses on the Company’s cash equivalents and short-term investments aggregated by category and the length of time such aggregated investments have been in a continuous unrealized loss position as of the periods presented (in thousands):
| Less Than 12 Months · 12 Months or Greater · Total | ||||||
|---|---|---|---|---|---|---|
| Carrying Value | Gross Unrealized Losses | Carrying Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | |
| U.S. Agency securities | $36,247 | $(113) | $9,448 | $(40) | $45,695 | $(153) |
| Commercial paper | 37,421 | (20) | — | — | 37,421 | (20) |
| Corporate debt securities | 168,986 | (675) | 13,195 | (17) | 182,181 | (692) |
| U.S. Treasury securities | 392,924 | (704) | 18,124 | (39) | 411,048 | (743) |
| Total cash equivalents and short-term investments | $635,578 | $(1,512) | $40,767 | $(96) | $676,345 | $(1,608) |
| Less Than 12 Months · 12 Months or Greater · Total | ||||||
|---|---|---|---|---|---|---|
| Carrying Value | Gross Unrealized Losses | Carrying Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | |
| U.S. Agency securities | $35,979 | $(53) | $11,386 | $(83) | $47,365 | $(136) |
| Commercial paper | 15,462 | (2) | — | — | 15,462 | (2) |
| Corporate debt securities | 85,998 | (192) | 15,485 | (58) | 101,483 | (250) |
| U.S. Treasury securities | 139,567 | (192) | 41,193 | (199) | 180,760 | (391) |
| Total cash equivalents and short-term investments | $277,006 | $(439) | $68,064 | $(340) | $345,070 | $(779) |
The following table classifies the Company’s short-term investments by contractual maturities (in thousands):
| April 30, 2024 | January 31, 2024 | |||
|---|---|---|---|---|
| Amortized cost | Fair Value | Amortized cost | Fair Value | |
| Due within 1 year | $500,465 | $499,318 | $619,286 | $618,765 |
| Due between 1 year to 2 years | 142,278 | 141,855 | 128,855 | 129,524 |
| Total | $642,743 | $641,173 | $748,141 | $748,289 |
All available-for-sale securities have been classified as current, based on management’s ability to use the funds in current operations.
Liabilities are measured at fair value on a recurring basis. The Company hascontingent cash consideration from business acquisitions which is determined based upon the satisfaction of certain defined operational milestones and remeasured at fair value at each reporting period through earnings. As the fair value is based on unobservable inputs, the liability is included in Level 3 of the fair value measurement hierarchy.
The Company reassessed the fair value of outstanding operational milestones and there was no change during the three months ended April 30, 2024 and 2023. The Company had$3.7 million and$3.6 million of Level 3 contingent consideration as of April 30, 2024 and January 31, 2024, respec tively. Interest accretion expense on contingent cash consideration was immaterial for the three months ended April 30, 2024 and 2023.
- Supplemental Financial Statement Information
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following (in thousands):
| April 30, 2024 | January 31, 2024 | |
|---|---|---|
| Income tax liability related to BAPA (1) | $265,254 | $258,675 |
| Accrued expenses | 21,015 | 11,499 |
| ESPP employee contributions | 6,912 | 2,827 |
| Acquisition related liabilities (2) | 3,766 | 3,608 |
| Income taxes payable | 3,380 | 2,212 |
| Customer refunds payable | 3,335 | 3,019 |
| Indirect taxes payable | 2,701 | 3,928 |
| Operating lease liabilities, current | 371 | 410 |
| Total accrued expenses and other current liabilities | $306,734 | $286,178 |
(1)Refer to “Note 12. Income Taxes” for a discussion on the unrecognized tax benefits related to the BAPA.
(2)$0.1 million relates to Oxeye acquisition founder holdback (see Note 6. Business Combination) and $3.7 million relates to Opstrace acquisition.
Other Income (Expense), Net
Other income (expense), net consisted of the following (in thousands):
| Three Months Ended April 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Foreign exchange gains (losses), net | $(637) | $274 |
| Other income (expense), net | 70 | (21) |
| Total other income (expense), net | $(567) | $253 |
- Business Combination
On March 20, 2024 (the “Acquisition Date”), the Company completed the acquisition of Oxeye Security Limited (“Oxeye”), a cloud-native application security and risk management solution company based in Israel. The Company believes this acquisition will allow the Company to strengthen its product offerings.
The transaction was accounted for as a business combination. The Acquisition Date fair value of the consideration transferred consisted of the following (in thousands):
| Closing cash consideration | $16,737 |
|---|---|
| Cash held in escrow | 3,593 |
| Total consideration | $20,330 |
Total consideration includes $3.6 million deposited in an escrow account as partial security for post-closing indemnification claims made within 15 months of the Acquisition Date. As the Company is not the legal owner of the escrow account, it is not recorded on the condensed consolidated balance sheet as of April 30, 2024.
As part of the acquisition, there was also a holdback in the amount of $3.2 million (the “holdback”). The holdback will be paid to thetwo co-founders (the “founder holdback”) inthree equal tranches of 33.3%. The first such payment will be paid if certain milestones are achieved on or before the first anniversary of the closing date, provided such founder is employed by the Company on the first anniversary. The second and third tranches will be paid provided such founder is employed by the Company on the second and third anniversaries of the closing dates, respectively. As the founder holdback arrangement represents compensation for post-combination services, the Company has excluded the entire $3.2 million from the purchase price to be allocated, and will recognize the amount as expense over the period of services rendered after factoring in the likelihood of achieving the milestones. During the three months ended April 30, 2024, $0.1 million of the founder holdback was expensed by the Company in general and administrative expenses in its condensed consolidated statement of operations.
Acquisition related transaction costs were $1.3 million for the three months ended April 30, 2024 and were expensed by the Company in general and administrative expenses in its condensed consolidated statement of operations.
The Company recorded the assets acquired and liabilities assumed at their estimated fair values, with the difference between the fair value of the net assets acquired and the purchase consideration reflected in goodwill. The total purchase price of $20.3 million was allocated using information available to the Company at the time of acquisition. The Company may continue to adjust the preliminary purchase price allocation after obtaining more information regarding asset valuations, liabilities assumed, tax-related items and revisions of preliminary estimates. During the three months ended April 30, 2024, there were no measurement period adjustments identified and recorded.
The following table reflects the fair values of assets acquired and liabilities assumed (in thousands):
| Cash and cash equivalents | $120 |
|---|---|
| Developed technology | 16,276 |
| Goodwill | 8,055 |
| Prepaid expenses and other current assets | 121 |
| Accrued expenses and payroll | (3,582) |
| Deferred tax liability | (660) |
| Net assets acquired | $20,330 |
As of March 20, 2024, developed technology of the acquired business had an estimated useful life ofthree years. The fair value of the developed technology intangible asset was estimated using the replacement cost method, which utilizes assumptions for the cost to replace it, such as time and resources required, as well as a theoretical profit margin and opportunity costs. The goodwill is primarily attributed to the synergies expected to be realized following the acquisition. The goodwill is not deductible for Israeli income tax purposes.
Results of operations of the business acquired have been included in the Company’s condensed consolidated financial statements subsequent to the date of acquisition. The revenue and net income (loss) earned by the business acquired following the acquisition are not material to the Company’s condensed consolidated results of operations; and accordingly, pro forma financial statements have not been presented.
- Goodwill and Intangible Assets, Net
Goodwill
The carrying amount of goodwill was as follows (in thousands):
| Carrying Amount | |
|---|---|
| Balance as of January 31, 2024 | $8,145 |
| Acquisition of Oxeye | 8,055 |
| Foreign currency translation adjustments | (130) |
| Balance as of April 30, 2024 | $16,070 |
There wasno goodwill impairment for any periods presented.
Intangible Assets
Intangible assets, net consisted of the following (in thousands):
| April 30, 2024 (1) | Gross Carrying Amount | Accumulated Amortization | Net Book Value | Weighted average remaining amortization period (years) |
|---|---|---|---|---|
| Developed technology from business combination | $22,192 | $(5,555) | $16,637 | 2.5 |
| Developed technology from asset acquisitions | 906 | (906) | — | 0.0 |
| Total | $23,098 | $(6,461) | $16,637 |
| January 31, 2024 | Gross Carrying Amount | Accumulated Amortization | Net Book Value | Weighted average remaining amortization period (years) |
|---|---|---|---|---|
| Developed technology from business combination | $6,200 | $(4,467) | $1,733 | 0.8 |
| Developed technology from asset acquisitions (1) | 914 | (914) | — | 0.0 |
| Total | $7,114 | $(5,381) | $1,733 |
(1) The amounts in the tables above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying intangibles.
Amortization expense was $1.1 million and $0.6 million for the three months ended April 30, 2024 and 2023, respectively.
As of April 30, 2024, future amortization expense related to the intangibles assets is expected to be as follows (in thousands):
| Fiscal Years | |
|---|---|
| 2025 | $5,221 |
| 2026 | 5,330 |
| 2027 | 5,330 |
| 2028 | 756 |
| Total future amortization | $16,637 |
- Team Member Benefit Plans
The Company contributes to defined contribution plans in a number of countries including a 401(k) savings plan for U.S. based team members and defined contribution arrangements in the United Kingdom, Australia, New Zealand and select other countries based on the legislative and tax requirements of the respective countries. Total contributions to these plans were$1.8 million and $1.7 million for thethree months ended April 30, 2024 and 2023, respectively.
- Equity
Common Stock
The Company had shares of common stock reserved for future issuance as follows (in thousands):
| April 30, 2024 | January 31, 2024 | |
|---|---|---|
| Class A and Class B common stock | ||
| Options issued and outstanding | 7,880 | 8,503 |
| Shares available for issuance under Equity Incentive Plans | 30,067 | 24,868 |
| RSUs and PSUs issued and outstanding | 12,960 | 10,930 |
| Shares reserved for issuance to charitable organizations | 1,351 | 1,404 |
| ESPP | 6,974 | 5,398 |
| Total | 59,232 | 51,103 |
Equity Incentive Plans
In September 2021, the Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”) as a successor of the Company’s 2015 Equity Incentive Plan (together the “Plans”). Effective February 1, 2024, the number of shares available under the 2021 Plan was automatically increased by 7,877,919 shares pursuant to the terms of the 2021 Plan.
The awards available for grant under the above Plans for the periods presented were as follows (in thousands):
| April 30, 2024 | January 31, 2024 | |
|---|---|---|
| Available at beginning of period | 24,868 | 21,483 |
| Awards authorized | 7,878 | 7,557 |
| RSUs and PSUs granted | (3,159) | (6,258) |
| RSUs and PSUs canceled and forfeited | 418 | 1,292 |
| Options canceled and forfeited | 62 | 777 |
| Options repurchased | — | 17 |
| Available at end of period | 30,067 | 24,868 |
In the event that shares previously issued under the above Plans are reacquired by the Company, such shares shall be added to the number of shares then available for issuance under the 2021 Plan. In the event that an outstanding stock option for any reason expires or is canceled, the shares allocable to the unexercised portion of such stock option will be added to the number of shares then available for issuance under the 2021 Plan.
Both Plans allow the grantees to early exercise stock options.
Stock Options, RSUs and PSUs
The following table summarizes options activity under the Plans, and related information:
| Number of Stock Options Outstanding (in thousands) | Weighted Average Exercise Price | Weighted Average Remaining Years | Aggregate Intrinsic value (in millions) | |
|---|---|---|---|---|
| Balances at January 31, 2024 | 8,503 | $13.03 | 5.85 | $499.2 |
| Options granted | — | — | — | |
| Options exercised | (561) | 9.08 | — | |
| Options canceled | (6) | 10.11 | — | |
| Options forfeited | (56) | 18.79 | — | |
| Balances at April 30, 2024 | 7,880 | $13.27 | 5.63 | $312.6 |
| Options vested at April 30, 2024 | 6,213 | $11.98 | 5.37 | $251.6 |
| Options vested and expected to vest at April 30, 2024 | 7,880 | $13.27 | 5.63 | $312.6 |
During the three months ended April 30, 2024 and 2023, the Company recorded $3.5 million and $4.8 million stock-based compensation expenses related to options, respectively.
As of April 30, 2024, approximately $17.6 million of total unrecognized compensation cost was related to stock options granted, that is expected to be recognized over a weighted-average period of 1.4 years. The expected stock compensation expense remaining to be recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures.
The following table summarizes the Company’s RSU activity:
| Number of Shares (in thousands) (1) | Weighted-Averagegrant datefair value | |
|---|---|---|
| Balances at January 31, 2024 | 7,701 | $47.20 |
| Granted | 3,159 | 56.18 |
| Vested | (711) | 47.77 |
| Canceled/forfeited | (418) | 50.02 |
| Balances at April 30, 2024 | 9,731 | $49.93 |
(1) The table above does not include 3 million RSUs granted to the Company’s founder and the Chief Executive Officer (“CEO”) described below.
These RSUs are grants of shares of the Company’s common stock, the vesting of which is based on the requisite service requirement. Generally, the Company’s RSUs are subject to forfeiture and are expected to vest overtwo tofour years ratably on a combination of bi-annual and quarterly basis. During the three months ended April 30, 2024 and 2023, the Company recorded $35.5 million and $23.2 million stock-based compensation expenses related to RSUs, respectively.
As of April 30, 2024, approximately $468.5 million of total unrecognized compensation cost was related to RSUs granted to team members other than the CEO, that is expected to be recognized over a weighted-average period of 3.1 years. The expected stock compensation expense remaining to be recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures.
In June 2022, the Company granted 0.4 million PSUs to senior members of its management team subject to revenue performance condition and service conditions. The number of awards granted represents 100% of the target goal; under the terms of the awards, the recipient may earn between 0% and 200% of the original grant. The performance condition is setto be achieved in fiscal year 2025 and the service condition in calendar year 2025. The Company recorded $0.6 million and $0.4 million of stock-based compensation expense related to PSUs during thethree months ended April 30, 2024 and 2023, respectively. As of April 30, 2024, unrecognized stock-based compensation expense related to these PSUs was $2.3 million to be recognized over a period of 1.6 years.
CEO Performance Award
In May 2021, the Company granted 3 million RSUs tied to its Class B common stock to Sytse Sijbrandij, the Company’s co-founder and CEO, with an estimated aggregate grant date fair value of $8.8 million. During the three months ended April 30, 2024 and 2023, the Company recorded $0.4 million of stock-based compensation expense related to the CEO RSUs.
As measured from the grant date, the derived service period of the respective tranches ranges from 2 to 7 years. As of April 30, 2024, unrecognized stock-based compensation expense related to these RSUs was $3.9 million which will be recognized over 4.6 years.
2021 Employee Stock Purchase Plan (“ESPP”)
In September 2021, the Company’s board of directors and its stockholders approved the ESPP and participation of eligible team members. Effective as of February 1, 2024, the number of shares available under the ESPP was automatically increased by 1,575,583 shares pursuant to the terms of the 2021 ESPP.
The Company recorded $2.6 million and $4.5 million of stock-based compensation expense related to the ESPP during the three months ended April 30, 2024 and 2023, respectively. As of April 30, 2024, approximately $10.1 million of total unrecognized compensation cost was related to the ESPP that is expected to be recognized over 1.6 years.
Stock-Based Compensation Expense
The Company recognized stock-based compensation expense as follows (in thousands):
| Three Months Ended April 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Cost of revenue | $1,855 | $1,414 |
| Sales and marketing | 17,397 | 13,764 |
| Research and development | 12,336 | 11,702 |
| General and administrative | 10,664 | 5,450 |
| Total stock-based compensation expense (1) | $42,252 | $32,330 |
(1) The table above includes stock-based compensation of JiHu. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
The corporate income tax benefit recognized in thecondensed consolidated statements of operations for stock-based compensation expense was zero and$2.8 million forthe three months ended April 30, 2024 and 2023, respectively.
Charitable Donation of Common Stock
In September 2021, the Company’s board of directors approved the reservation of up to 1,635,545 shares of Class A common stock for issuance to charitable organizations. In March 2024 and 2023, the Company’s board of directors approved the donation of $11.8 million and $10.7 million aggregate principal amount of shares of Class A common stock to the GitLab Foundation (the “Foundation”), a California nonprofit public benefit corporation, respectively. The Foundation is also a related party as certain of the Company’s officers serve as directors of the Foundation. These donations shall occur infour equal quarterly distributions.
During the three months ended April 30, 2024 and 2023, the Company donated 53,226 shares and 80,742 shares of Class A common stock at fair value to the Foundation, respectively. The fair value of the common stock was determined based on the quoted market price on the grant date. The donation expense of $3.0 million and $2.7 million was recorded in general and administrative expense in the condensed consolidated statements of operations for the three months ended April 30, 2024 and 2023, respectively.
- Restructuring and Other Related Charges
In February 2024, the Company restructured certain departments to better align functions and recognized total restructuring charges of approximately $1.0 million during thethree months ended April 30, 2024.
In February 2023, the Company reduced its total global headcount by approximately 7%. As a result, the Company recognized total restructuring charges of approximately $9.0 million during the three months ended April 30, 2023, which consisted primarily of one-time severance and other termination benefit costs of $7.7 million, as well as accelerated stock-based compensation of $1.3 million.
The Company recognized severance and other termination benefit costs as follows (in thousands):
| Three Months Ended April 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Cost of revenue | $— | $417 |
| Research and development | — | 2,059 |
| Sales and marketing | 730 | 3,559 |
| General and administrative | 276 | 1,618 |
| Total (1) | $1,006 | $7,653 |
(1)Excludes stock-based compensation ofzero and $1.3 million for thethree months ended April 30, 2024 and 2023, respectively.
The changes in liabilities resulting from the restructuring charges and related accruals were as follows(in thousands):
| Balance as of January 31, 2024 | $188 |
|---|---|
| Charges | 1,006 |
| Cash payments | (1,176) |
| Balance as of April 30, 2024 (1) | $18 |
(1)Balance is included in accrued compensation and benefits on the condensed consolidated balance sheet as of April 30, 2024.
- Joint Venture and Equity Method Investment
Joint Venture
In February 2021, the Company along with Sequoia CBC Junyuan (Hubei) Equity Investment Partnership (Limited Partnership) and Suzhou Gaocheng Xinjian Equity Investment Fund Partnership (Limited Partnership) executed an investment agreement (the “Investment Agreement”) to establish GitLab Information Technology (Hubei) Co., LTD (“JiHu”), a legal entity in the People’s Republic of China. The Company accounted for JiHu as a variable interest entity and consolidated the entity in accordance with ASC Topic 810, Consolidation. As of April 30, 2024, the Company retains control over JiHu with its equity stake at approxima tely 54%.
JiHu maintains an employee stock option plan (“JiHu ESOP”) for its employees. As a result of forfeitures triggered by the departure of key executives during thethree months ended April 30, 2024 and 2023, the Company reversed stock-based compensation previously recorded which resulted in a $0.3 million gain and$2.5 million gain, respectively. As of April 30, 2024, approximately $1.2 million of total unrecognized compensation cost was related to the JiHu ESOP that is expected to be recognized over 3.6 years.
Operating Leases
JiHu entered into a new lease in March 2024 and has various non-cancelable long-term operating leases maturing by June 30, 2026 with total lease payments of $0.5 million and a total present value of lease liabilities of $0.5 million. In addition, there is one short-term lease for which the associated lease expense was immaterial during the three months ended April 30, 2024 and 2023.
The Company recognized $0.2 million of operating lease expense during the three months ended April 30, 2024 and 2023.
The table below presents supplemental information related to operating leases for the three months ended April 30, 2024 (in thousands, except weighted-average information):
| Weighted-average remaining lease term (in years) | 0.88 |
|---|---|
| Weighted-average discount rate | 3.6% |
| Right-of-use assets obtained in exchange for new operating lease liabilities | $284 |
| Cash paid for amounts included in the measurement of lease liabilities | $195 |
Selected Financial Information
Selected financial information of JiHu, post intercompany eliminations, is as follows (in thousands):
| Three Months Ended April 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Revenue | $1,646 | $1,464 |
| Cost of revenue | 484 | 491 |
| Gross profit | 1,162 | 973 |
| Operating expenses: | ||
| Sales and marketing | 1,635 | 2,084 |
| Research and development | (211) | 1,956 |
| General and administrative | 838 | (1,444) |
| Total operating expenses | 2,262 | 2,596 |
| Loss from operations | (1,100) | (1,623) |
| Interest income | 227 | 315 |
| Other income, net | 347 | 269 |
| Net loss before income taxes | (526) | (1,039) |
| Net loss | $(526) | $(1,039) |
| Net loss attributable to noncontrolling interest | $(243) | $(430) |
| April 30, 2024 | January 31, 2024 | |
|---|---|---|
| Cash and cash equivalents | $41,901 | $43,896 |
| Property and equipment, net | 357 | 489 |
| Operating lease right-of-use assets | 543 | 405 |
| Other assets | 3,884 | 2,835 |
| Total assets | $46,685 | $47,625 |
| Total liabilities | $6,071 | $6,080 |
Equity Method Investment
In April 2021, the Company reorganized Meltano Inc. (“Meltano”), now operating as Arch Data, Inc. (“Arch”), which started as an internal project within the Company in July 2018, into a separate legal entity.
The Company recorded an impairment charge of $8.9 million in other income (expense), net in thecondensed consolidated statement of operations during the year ended January 31, 2024 which reduced the equity method investment value tozero as of January 31, 2024.
During the three months ended April 30, 2024 and 2023, the Company recorded a loss from equity method investment ofzero and $0.7 million, net of tax on the condensed consolidated statements of operations, respectively.
- Income Taxes
For the three months ended April 30, 2024, the Company recorded income tax expense of $12.7 million on pretax loss of $42.2 million. The income tax expense for the three months ended April 30, 2024 was primarily related to an increase in tax expense for unrecognized tax benefits and the Company's foreign and domestic operations.
For thethree months ended April 30, 2023, the Company recorded income tax expense of$1.5 million on pretax loss of$50.7 million. The income tax expense for thethree months ended April 30, 2023 was primarily related to the Company's foreign and domestic operations.
The Company's provision for income taxes is based on its worldwide estimated annualized effective tax rate, except for jurisdictions for which a loss is expected for the year and no benefit can be realized for those losses, jurisdictions for which forecasted pre-tax income or loss cannot be estimated, and the tax effect of discrete items occurring during the period. The tax provision for jurisdictions for which a forecast cannot be estimated is based on actual taxes and tax reserves for the quarter.
Under the provisions of ASC 740, Income Taxes, the determination of the Company’s ability to recognize its deferred tax asset requires an assessment of both negative and positive evidence when determining the Company’s ability to recognize its deferred tax assets. As in prior years, the Company maintained that it was not more likely than not that the Company could recognize deferred tax assets in certain jurisdictions. The evidence evaluated by the Company included operating results during the most recent three-year period and future projections. More weight was given to historical results than to expectations of future profitability, which are inherently uncertain. Certain entities’ net losses in recent periods represented sufficient negative evidence to require a valuation allowance against its net deferred tax assets. This valuation allowance will be evaluated periodically and could be reversed partially or totally if business results have sufficiently improved to support realization of deferred tax assets.
As of April 30, 2024, unrecognized tax benefits were $398.3 million, of which $210.3 million would affect the effective tax rate if recognized. The Company has classified approximately $209.7 million of unrecognized tax benefit as current tax liability due to anticipated timing of the settlement of the bilateral advance pricing agreement (“BAPA”) with the U.S. Internal Revenue Service (“IRS”) and Dutch Tax Authority (“DTA”) and their associated payments, which are expected to be made within the next 12 months. The Company is unable to reasonably estimate the timing of remaining long-term payments or the amount by which the liability will increase or decrease.
It is the Company’s policy to classify accrued interest and penalties related to unrecognized tax benefits in provision for income taxes. Accrued interest and penalties were $56.7 million as of April 30, 2024 and $52.1 million as of January 2024, respectively.
The Company has been in BAPA negotiations between the IRS and the DTA relating to the Company’s transfer pricing arrangements between the United States and the Netherlands. In the year ended January 31, 2024, the Company for the first time discussed with the IRS and DTA a framework to finalize its transfer pricing arrangements for the proposed BAPA period consisting of tax years ending December 31, 2018 through January 31, 2027. The proposed agreements between the Company, the IRS and the DTA are not yet final; in anticipation of the agreements, $254.9 million of net tax liability was recorded in the year ended January 31, 2024, and an additional $8.7 million of net tax liability was recorded for the three months ended April 30, 2024. These amounts represent the unrecognized tax benefit relating to the BAPA. The unrecognized tax benefit represents the Company’s best estimate of the tax liability associated with the proposed agreements and their related effects.
As of April 30, 2024, the Company’s U.S. federal 2018 through 2022 tax years were open and subject to potential examination in one or more jurisdictions. In addition, in the United States, any net operating losses or credits that were generated in prior years but not yet fully utilized in a year that is closed under the statute of limitations may also be subject to examination. The Company is currently under examination in the Netherlands for the tax years ended December 31, 2015 and 2016. The Company expects negotiations to continue to the middle of fiscal year 2025. The Company believes that it has adequately reserved for the outcome of this audit. The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of its provision for income taxes. The Company continues to monitor the progress of ongoing discussions with tax authorities and the effect, if any, of the expected expiration of the statute of limitations in various taxing jurisdictions.
- Net Loss per Share
The following table sets forth basic and diluted loss per share for each of the periods presented (in thousands, except per share data):
| Three Months Ended April 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Numerator: | ||
| Net loss attributable to GitLab | $(54,644) | $(52,469) |
| Denominator: | ||
| Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted | 158,157 | 151,692 |
| Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted | $(0.35) | $(0.35) |
Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands):
| As of | ||
|---|---|---|
| April 30, 2024 | January 31, 2024 | |
| Shares subject to outstanding common stock options | 7,880 | 8,503 |
| Unvested restricted stock in connection with business combination | 2 | 3 |
| Unvested early exercised stock options | 17 | 22 |
| Unvested RSUs and PSUs | 12,960 | 10,930 |
| Shares subject to the ESPP | 155 | 63 |
| Total | 21,014 | 19,521 |
- Commitments and Contingencies
Contractual Obligations and Commitments
The Company’s purchase oblig ations of $136.8 million as of April 30, 2024, represent third-party non-cancelable hosting infrastructure agreements, subscription arrangements and other commitments used in the ordinary course of business to meet operational requirements.
Loss Contingencies
In accordance with ASC 450, Loss Contingencies, the Company accrues for contingencies when losses become probable and reasonably estimable. Accordingly, the Company has recorded an estimated liability related to certain labor matters regarding its use of contractors in certain foreign countries. As of April 30, 2024 and January 31, 2024, the estimated liability relating to these matters was $2.1 million and $2.2 million recorded in other non-current liabilities on the condensed consolidated balance sheets, respectively.
Warranties and Indemnifications
The Company enters into service level agreements with customers which warrant defined levels of uptime and support response times and permit those customers to receive credits for prepaid amounts in the event that those performance and response levels are not met. To date, the Company has not experienced any significant failures to meet defined levels of performance and response. In connection with the service level agreements, the Company has not incurred any significant costs and has not accrued any liabilities in the condensed consolidated financial statements.
In the ordinary course of business, the Company enters into contractual arrangements under which the Company agrees to provide indemnification of varying scope and terms to business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, intellectual property infringement claims made by third parties, and other liabilities relating to or arising from the Company’s platform or the Company’s acts or omissions. In these circumstances, payment may be conditional on the other party making a claim pursuant to the procedures specified in the particular contract. Further, the Company’s obligations under these agreements may be limited in terms of time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments.
In addition, the Company has agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by the Company, arising out of that person’s services as the Company’s director or officer or that person’s services provided to any other company or enterprise at the Company’s request. The Company maintains director and officer insurance coverage that may enable the Company to recover a portion of any future amounts paid.
Legal Proceedings
The Company is, and from time to time, may become involved in legal proceedings or be subject to claims arising in the ordinary course of its business. The Company is not presently a party to any legal proceedings that in the opinion of management, if determined adversely to the Company, would individually or taken together have a material adverse effect on its business, financial condition or operating results.
Defending such proceedings is costly and can impose a significant burden on management and team members. The results of any current or future litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact on the Company because of defense and settlement costs, diversion of management resources and other factors.
- Subsequent Event
On May 23, 2024, the Company completed its acquisition of certain assets, primarily software intellectual property, of Rezilion Inc. and its subsidiary, Rezilion Ltd. (collectively, “Rezilion”) for approximately $7.3 million in cash, subject primarily to a one-time payment to the Israel Innovation Authority and settlement of a bank borrowing, and the assumption of select liabilities. Select employees of Rezilion have also joined the Company.
Rezilion has developed software security solutions and this transaction will allow the Company to strengthen its product offerings.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.